Millions of Medicare beneficiaries will become eligible to receive obesity medicines for $50 a month
Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels
Several potential mechanisms have been proposed, though evidence specifically linking them to panic symptoms with Wegovy is limited: Increased heart rate : GLP-1 receptor agonists can increase heart rate, which may be perceived as anxiety or palpitations Hypoglycaemia : Though uncommon with Wegovy alone in people without diabetes, low blood sugar can trigger anxiety-like symptoms (risk increases if taking insulin or sulfonylureas) Gastrointestinal distress : Severe nausea or abdominal discomfort may provoke anxiety or panic responses in susceptible individuals Individual susceptibility varies considerably
While one case report does not establish causation, it is worth noting when making a choice between the two options
Sold as Ozempic for type 2 diabetes and Wegovy for weight management, it is administered as a once-weekly injection
Celebrities have been striving for health in 2025, with many dropping significant amounts of weight in many cases with the help of GLP-1 medications like Ozempic